BL
BioLife Sciences Inc.
BLFE · OTC
$0.00 +0.00% (+$0.00)
1M +0.00%
Market Cap $156.7K
P/E Ratio -
Div. Yield -
ROE -
Piotroski F-Score Moderate
4/9Valuation
-
N/A P/B N/A
EV/FFO N/A
P/E N/A
Growth
-
N/A Book val. growth N/A
FCF growth N/A
EPS growth N/A
Profitability
-
N/A FCF margin N/A
Op. margin N/A
Gross margin N/A
Quality
-
N/A Asset turnover N/A
ROA N/A
ROIC N/A
Debt
-
N/A Net debt/EBITDA N/A
Int. coverage N/A
Debt/Equity N/A
Stability
33 /100
Unstable Profitable years 0
Beta -2,290.12x
EPS volatility N/A
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about BLFE
Online
Sector
Healthcare
Industry
Medical - Instruments & Supplies
CEO
Justin De Four
Employees
3
Headquarters
Henderson